Published May 18, 2022
| Version v1
Preprint
Open
Projected health impact of post-discharge malaria chemoprevention among children under the age of five years with severe malarial anaemia in Africa: a modelling analysis
Authors/Creators
Authors/Creators
- 1. MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Imperial College, London, United Kingdom
- 2. Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya
- 3. Makerere University College of Health Sciences, Kampala, Uganda
- 4. Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom
- 5. College of Medicine, University of Malawi, Blantyre, Malawi
- 6. Centre for International Health (CIH) and Section for Ethics and Health Economics, Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway
- 7. Big Data Institute, University of Oxford, Oxford, United Kingdom
- 8. Malaria Atlas Project, Telethon Kids Institute, Perth Children's Hospital, 15 Hospital Avenue, Nedlands, Australia
- 9. International Statistics and Epidemiology Group, London School of Hygiene and Tropical Medicine, London, United Kingdom
- 10. Liverpool School of Tropical Medicine, Liverpool, United Kingdom
- 11. School of Global and Public Health, Kamuzu University of Health Sciences (KUHeS), Blantyre, Malawi
- 12. Section for Ethics and Health Economics, Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway
Description
Supplementary report provided to the WHO/GMP Guideline Development Group on Malaria Chemoprevention for “Section 4.2.5 Post-discharge malaria chemoprevention (PDMC)” of the WHO Guidelines for malaria, 3 June 2022.